☆ 4.6 Article

Theranostics in Oncology-Thriving, Now More than Ever

DIAGNOSTICS (2021)

Related references

Note: Only part of the references are listed.

Article Radiology, Nuclear Medicine & Medical Imaging

Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis

Christian Mirian et al.

Summary: The meta-analysis of individual patient data included 111 patients with refractory meningiomas treated with SSTR-targeted PRRT, showing that the treatment was well tolerated, achieved disease control in most cases, and had promising results in terms of PFS and OS.

JOURNAL OF NUCLEAR MEDICINE (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET

Francesco Ceci et al.

Summary: The development of consensus guidelines for interpretation of PSMA-PET aims to provide consistent clinical reports, increase data reproducibility in clinical trials, and assist clinicians in making treatment decisions. An expert panel actively participated in a modified Delphi consensus process to implement structured reporting for PSMA-PET. The E-PSMA standardized reporting guidelines supported by the European Association of Nuclear Medicine offer consensus statements among experts in PSMA-PET imaging to harmonize diagnostic interpretation criteria.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Article Medicine, General & Internal

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

Michael S. Hofman et al.

Summary: [Lu-177]Lu-PSMA-617 showed a higher PSA response and fewer grade 3-4 adverse events compared to cabazitaxel in men with metastatic castration-resistant prostate cancer.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after 177Lu-PSMA-617 Radioligand Therapy

Friederike Voelter et al.

Summary: The study found that single index-lesion-based SPECT dosimetry correlates well with the response to PSMA-RLT, suggesting it may be a fast and feasible dosimetry approach for clinical routine.

DIAGNOSTICS (2021)

Add to Collection

Article Medicine, General & Internal

Wnt/beta-Catenin Signaling Regulates CXCR4 Expression and [Ga-68] Pentixafor Internalization in Neuroendocrine Tumor Cells

Alexander Weich et al.

Summary: Loss of Somatostatin Receptor 2 (SSTR2) expression and rising CXC Chemokine Receptor Type 4 (CXCR4) expression are associated with dedifferentiation in neuroendocrine tumors (NET). Activation of Wnt/beta-catenin signaling may promote a more aggressive phenotype in NET. Modulation of the Wnt pathway influences CXCR4 expression and function in NET cell lines, suggesting it may enhance the efficacy of CXCR4-directed therapies or inhibit CXCR4-dependent proliferative signaling.

DIAGNOSTICS (2021)

Add to Collection

Article Medicine, General & Internal

Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with Lu-177-PSMA

Sobhan Moazemi et al.

Summary: This study aimed to analyze the overall survival of prostate cancer patients treated with Lu-177-PSMA therapy by examining radiomics features and radiomics signature from pretherapeutic Ga-68-PSMA-PET/CT findings, as well as patient-specific clinical parameters. SUVMin, kurtosis, RS, SUVMean, Hemoglobin1, C-reactive protein1, and ECOG1 were found to have potential for predicting OS in these patients.

DIAGNOSTICS (2021)

Add to Collection

Article Medicine, General & Internal

Predictive and Prognostic Impact of Blood-Based Inflammatory Biomarkers in Patients with Gastroenteropancreatic Neuroendocrine Tumors Commencing Peptide Receptor Radionuclide Therapy

Fiona Ohlendorf et al.

Summary: The study evaluated the early predictive and prognostic significance of systemic inflammation markers in patients receiving PRRT for GEP-NETs. Inflammatory biomarkers and indexes showed significant differences in non-responders, with CRP, ANC, and PCM being notably higher. Changes in tumor burden were associated with CRP and NLR, indicating potential predictive value for treatment response and prognosis.

DIAGNOSTICS (2021)

Add to Collection

Article Medicine, General & Internal

Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate Cancer

Wajahat Khatri et al.

Summary: The use of point-spread function (PSF) reconstructions in F-18-DCFPyL PET imaging can help re-categorize a small number of indeterminate PSMA-RADS-3A lesions as more definitive PSMA-RADS-4 lesions.

DIAGNOSTICS (2021)

Add to Collection

Article Medicine, General & Internal

CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas

Alexander Weich et al.

Summary: The study aimed to evaluate the diagnostic potential of CXCR4-directed PET tracer Ga-68-Pentixafor in patients with NEC, revealing that while Ga-68-Pentixafor could detect tumor lesions, F-18-FDG PET/CT remains the more accurate reference standard for this purpose.

DIAGNOSTICS (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear Medicine

Lilja B. Solnes et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Diagnostic Use of Post-therapy 131I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma

Hiroshi Wakabayashi et al.

DIAGNOSTICS (2020)

Add to Collection

Article Medicine, General & Internal

Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment?

Christoph Wetz et al.

DIAGNOSTICS (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

The Future of Nuclear Medicine, Molecular Imaging, and Theranostics

Wolfgang A. Weber et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume Definition

Josefine Graef et al.

DIAGNOSTICS (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation

Sabine Maurer et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT

Matthias Eiber et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

Add to Collection

Editorial Material Urology & Nephrology

PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA-targeted PET Imaging Studies

Steven P. Rowe et al.

EUROPEAN UROLOGY (2018)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

The Relevance of Dosimetry in Precision Medicine

Michael Lassmann et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

Add to Collection

Article Oncology

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

Michael S. Hofman et al.

LANCET ONCOLOGY (2018)

Add to Collection

Review Medicine, Research & Experimental

The theranostic promise for Neuroendocrine Tumors in the late 2010s-Where do we stand, where do we go?

Rudolf A. Werner et al.

THERANOSTICS (2018)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging

Sara Sheikhbahaei et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

Add to Collection

Article Endocrinology & Metabolism

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents

Marianne Pavel et al.

NEUROENDOCRINOLOGY (2017)

Add to Collection

Article Medicine, General & Internal

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

J. Strosberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Article Gastroenterology & Hepatology

Neuropendocrine Cancer, Therapeutic Strategies in G3 Cancers

Anja Rinke et al.

DIGESTION (2017)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease

Ken Herrmann et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Add to Collection

Article Medicine, General & Internal

Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

Martin Schlumberger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.